Pharmaceutical drug sales are sold through various channels such as retail, mail orders, clinics and hospitals. Retail channel generate sales followed by mail orders, and collectively account for more than 50% of the pharmaceutical drugs sales. Hospital however account for a smaller share of about 8.6% of the total sales. This report exclusively studies the market for pharmaceutical drugs that are sold or delivered to patients in hospital settings.

Global hospital pharmaceutical drugs market is segmented according to major therapeutic areas, which include: cardiology, oncology, nephrology and urology, neurology, pain and infection. Market for these major therapeutic areas has been further assessed according to drug classes. Cardiology segment is further divided into diuretic drugs, calcium channel inhibitors, anti-cholinergic agents, anti-arrhythmic agents, anti-adrenergic agents, and others (ACE inhibitors, angiotensin receptor blockers, anticoagulants). Oncology segment is further segmented into immunomodulating agents, alkylating agents, anti-metabolites, hormonal agents, and miscellaneous drugs. Nephrology and urology segment is further divided into diuretic drugs, anti-hypertensive agents, phosphate binders, anti-cholinergic agents and 5-alpha-reductase inhibitors. Neurology segment is divided into anti-anxiety, anti-migraine, anti-depressant and anti-psychotic drugs. Market for pain management drugs has been divided into anti-convulsant drugs, anesthetics, nonsteroidal anti-inflammatory drugs (NSAID), opioids, and non-narcotic analgesic drugs. Similarly anti-infective drugs market has been segmented into anti-bacterial drugs, anti-viral drugs, anti-fungal drugs and anti-parasite drugs. The report also provides a detailed list of potential phase III candidates for each of the therapeutic areas.

Browse the full Hospital Pharmaceuticals Market Report at :
http://www.transparencymarketresearch.com/hospital-pharmaceuticals-market.html

The market has been further studied from the point of view of major diseases in these therapeutic areas. Thus the cardiology market has been studied considering coronary heart diseases, stroke, high blood pressure (hypertension), heart failure and other cardiovascular diseases. Oncology drugs market has been studied for lung cancer, breast cancer, colorectal cancer, prostate cancer, and others. Nephrology and urology drugs market is studied for acute kidney failure, chronic kidney diseases, glomerular diseases, diabetes and other diseases. Neurology market has been studied for epilepsy, Alzheimer’s disease, Parkinson’s disease, multiple sclerosis, stroke and other diseases.

Market for pain has been studied for neuropathic pain, fibromyalgia, osteoarthritis, rheumatoid arthritis, cancer pain and others. The infection market is studied for major infectious disease such as tuberculosis, pneumonia, hepatitis A, hepatitis B, Candida infections, fungal meningitis, shigellosis, amoebiasis and other infections. The report also provides insights for various branded and blockbuster drugs under various therapeutic drug class along with other details such as manufacturer, approval date and the patent expiry.

Browse the full Hospital Pharmaceuticals Market press release at :
http://www.transparencymarketresearch.com/pressrelease/hospital-pharmaceuticals-market.htm

Furthermore the global market for hospital pharmaceutical drugs has been segmented into major geographies including North America, Europe, Asia Pacific and Rest of the World. Each of the market segments and sub-segments have been analyzed on the basis of current and future market size for the period 2012 to 2020, in terms of revenue (USD million), considering 2012 and 2013 as the base years. The compounded annual growth rate (% CAGR) for each market segment has been provided for the forecast period 2014 to 2020 along with the estimations of market size. The report also provides detailed Porter’s five forces analysis of the hospital pharmaceutical drugs market.

Based on in-depth analysis and comprehensive market study, key factors driving and restraining the market have been discussed. Moreover lucrative opportunities and relevant recommendations for sustainable growth in the market also have been suggested. A detailed event impact analysis considers regulatory approvals and patent expiry of major drugs in the hospital pharmaceutical market. Value chain analysis, market share analysis and market attractiveness analysis further provides a complete market understanding.

Get Free Sample Report Hospital Pharmaceuticals Market :
http://www.transparencymarketresearch.com/sample/sample.php?flag=s&rep_id=3535

Key players profiled in the report include AstraZeneca plc, Bayer AG, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline plc, Johnson & Johnson, Merck & Co., Novartis, and Pfizer, Inc.

The Global Hospital Pharmaceuticals Market is segmented into the following categories:

Cardiology

Anti-Adrenergic Drugs

Calcium Channel Blockers

Diuretic Drugs

Anti-Arrhythmic Drugs

Others

Oncology

Alkylating Agents

Anti-Metabolites

Hormonal Agents

Immunomodulating Agents

Miscellaneous Drugs

Nephrology and Urology

Diuretic Agents

Anti-Hypertensive Agents

Phosphate Binders

Anticholinergic Drugs

5-Alpha Reductase Inhibitors

Neurology

Anti-Anxiety Agents

Detail2Anti-Migraine Drugs

Antidepressant Drugs

Anti-Psychotic Drugs

Pain

Anticonvulsant Drugs

Anesthetic Drugs

Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)

Opioids

Non-Narcotics Analgesic Drugs

Infection

Antibacterial Drugs

Antiviral Drugs

Antifungal Drugs

Antiparasite Drugs

Global Hospital Pharmaceuticals Market, by Major Indications

Cardiology

Coronary Heart Diseases

Stroke

High Blood Pressure

Heart Failure

Others

Oncology

Lung Cancer

Breast Cancer

Colorectal Cancer

Prostate Cancer

Others

Nephrology and Urology

Acute Kidney Failure

Chronic Kidney Diseases

Glomerular Diseases

Diabetes

Others

Neurology

Epilepsy

Alzheimer;s Disease

Parkinson;s Disease

Multiple Sclerosis

Others

Pain

Neuropathic Pain

Fibromyalgia

Osteoarthritis

Rheumatoid Arthritis

Cancer Pain

Infection

Detail1Tuberculosis

Pneumonia

Hepatitis A

Hepatitis B

Candida Infection

Fungal Meningitis

Shigellosis

Amoebiasis

Other

Global Hospital Pharmaceuticals Market, by Geography

North America

Europe

Asia Pacific

Rest of the World (RoW)

About Us :

Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather, and analyze information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.